Advertisement
Screener

Adhera Therapeutics, Inc. Capital Expenditures

Adhera Therapeutics, Inc. Capital Expenditures

Adhera Therapeutics, Inc. reported Capital Expenditures of $3.00 thousand for the 12-month period ending 2011-12-31, per its 10-K filed 2014-07-22.

Discontinued › Cash Flow › Investing Activities

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2014-07-22

  • Adhera Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2011-12-31 was $3.00K, a 86.96% decline year-over-year.
  • Adhera Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2011-09-30 was $0.00, a 100.00% decline year-over-year.
  • Adhera Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2010-12-31 was $23.00K.
  • Adhera Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2010-09-30 was $223.00K.
  • Adhera Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2011 was $3.00K, a 99.26% decline from fiscal 2010.
  • Adhera Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2010 was $404.00K.
Period endPayments to Acquire Property, Plant, and Equipment 3 monthPayments to Acquire Property, Plant, and Equipment 6 monthPayments to Acquire Property, Plant, and Equipment 9 monthPayments to Acquire Property, Plant, and Equipment 12 month
2011-12-31$3.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-22
$3.00K
derived: sum of 2 quarters · filed 2014-07-22
$3.00K
10-K · filed 2014-07-22
2011-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-10
$0.00
10-Q · filed 2011-11-10
2011-06-30$0.00
10-Q · filed 2011-08-11
2010-12-31$23.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-10-10
$246.00K
derived: sum of 2 quarters · filed 2012-10-10
$404.00K
10-K · filed 2012-10-10
2010-09-30$223.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-10
$381.00K
10-Q · filed 2011-11-10
2010-06-30$158.00K
10-Q · filed 2011-08-11